176 related articles for article (PubMed ID: 23520489)
1. Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.
Westreich D; Maskew M; Evans D; Firnhaber C; Majuba P; Sanne I
PLoS One; 2013; 8(3):e58117. PubMed ID: 23520489
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and virologic response to antiretroviral therapy in South Africa.
Westreich D; Cole SR; Nagar S; Maskew M; van der Horst C; Sanne I
PLoS One; 2011; 6(8):e22778. PubMed ID: 21829650
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
4. Prevalent pregnancy, biological sex, and virologic response to antiretroviral therapy.
Westreich D; Evans D; Firnhaber C; Majuba P; Maskew M
J Acquir Immune Defic Syndr; 2012 Aug; 60(5):489-94. PubMed ID: 22487586
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir use and pregnancy among women initiating HAART.
Maskew M; Westreich D; Firnhaber C; Sanne I
AIDS; 2012 Nov; 26(18):2393-7. PubMed ID: 22951630
[TBL] [Abstract][Full Text] [Related]
6. Incidence of pregnancy after initiation of antiretroviral therapy in South Africa: a retrospective clinical cohort analysis.
Westreich D; Maskew M; Rubel D; MacDonald P; Jaffray I; Majuba P
Infect Dis Obstet Gynecol; 2012; 2012():917059. PubMed ID: 22778536
[TBL] [Abstract][Full Text] [Related]
7. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
[TBL] [Abstract][Full Text] [Related]
8. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.
Anastos K; Barrón Y; Miotti P; Weiser B; Young M; Hessol N; Greenblatt RM; Cohen M; Augenbraun M; Levine A; Muñoz A;
Arch Intern Med; 2002 Sep; 162(17):1973-80. PubMed ID: 12230420
[TBL] [Abstract][Full Text] [Related]
9. The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy.
Anastos K; Barrón Y; Cohen MH; Greenblatt RM; Minkoff H; Levine A; Young M; Gange SJ
Ann Intern Med; 2004 Feb; 140(4):256-64. PubMed ID: 14970148
[TBL] [Abstract][Full Text] [Related]
10. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
11. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters.
Writing Committee for the CASCADE Collaboration
Arch Intern Med; 2011 Sep; 171(17):1560-9. PubMed ID: 21949165
[TBL] [Abstract][Full Text] [Related]
12. Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.
Murphy K; Hoover DR; Shi Q; Cohen M; Gandhi M; Golub ET; Gustafson DR; Pearce CL; Young M; Anastos K
AIDS; 2013 Sep; 27(15):2413-23. PubMed ID: 24037210
[TBL] [Abstract][Full Text] [Related]
13. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.
Murphy EL; Collier AC; Kalish LA; Assmann SF; Para MF; Flanigan TP; Kumar PN; Mintz L; Wallach FR; Nemo GJ;
Ann Intern Med; 2001 Jul; 135(1):17-26. PubMed ID: 11434728
[TBL] [Abstract][Full Text] [Related]
14. Reduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and Mozambique.
Liotta G; Mancinelli S; Nielsen-Saines K; Gennaro E; Scarcella P; Magid NA; Germano P; Jere H; Guidotti G; Buonomo E; Ciccacci F; Palombi L; Marazzi MC
PLoS One; 2013; 8(8):e71653. PubMed ID: 23990966
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapeutic drug monitoring in HIV-infected pregnant women: maternal immunovirological outcome at delivery and during the 18 month follow-up period.
Nicastri E; Ivanovic J; Signore F; Tempestilli M; Bellagamba R; Viscione M; Pisani G; Vallone C; Tommasi C; Gallo AL; De Nardo P; Pucillo PL; Narciso P
Curr HIV Res; 2012 Oct; 10(7):606-13. PubMed ID: 22762419
[TBL] [Abstract][Full Text] [Related]
16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of pregnancy among a cohort of HIV-positive women initiating antiretroviral therapy in Mbarara, Uganda.
Kaida A; Matthews LT; Kanters S; Kabakyenga J; Muzoora C; Mocello AR; Martin JN; Hunt P; Haberer J; Hogg RS; Bangsberg DR
PLoS One; 2013; 8(5):e63411. PubMed ID: 23704906
[TBL] [Abstract][Full Text] [Related]
18. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models.
Cole SR; Hernán MA; Robins JM; Anastos K; Chmiel J; Detels R; Ervin C; Feldman J; Greenblatt R; Kingsley L; Lai S; Young M; Cohen M; Muñoz A
Am J Epidemiol; 2003 Oct; 158(7):687-94. PubMed ID: 14507605
[TBL] [Abstract][Full Text] [Related]
19. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing albuminuria predicts AIDS and non-AIDS mortality in women initiating antiretroviral therapy.
Wyatt CM; Hoover DR; Shi Q; Tien PC; Karim R; Cohen MH; Goderre JL; Seaberg EC; Lazar J; Young MA; Klotman PE; Anastos K
Antivir Ther; 2011; 16(4):591-6. PubMed ID: 21685547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
